Xiahuo Pingwei San attenuated intestinal inflammation in dextran sulfate sodium-induced ulcerative colitis mice through inhibiting the receptor for advanced glycation end-products signaling pathway.
Our study demonstrated that XHPWS effectively alle <i>via</i>tes colitis symptoms and inflammation in UC mice, potentially through the regulation of the AGE-RAGE pathway. These findings provide strong evidence for the therapeutic potential of XHPWS in UC treatment, thereby broadening its clinical applications.
Authors
- Qing Luo (ORCID: https://orcid.org/0000-0003-1643-0307)
- Weibo Dai (ORCID: https://orcid.org/0000-0002-0719-4026)
- Gengting Dong
- Jianhong Han (ORCID: https://orcid.org/0009-0006-5496-4595)
- Peng Weiwen
- Huang Jiaen
Institutions
- Macau University of Science and Technology (MO)
- University of Macau (MO)
- Shanghai University of Traditional Chinese Medicine (CN)
- Traditional Chinese Medicine Hospital of Kunshan (CN)
- Zhongshan Hospital (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-04-01
- DOI
- https://doi.org/10.19852/j.cnki.jtcm.2025.02.006
- Primary Topic
- Advanced Glycation End Products research
- Type
- article
- Field-Weighted Citation Impact
- 0.00